Citius Oncology Inc.CTORNASDAQ
Loading
PB Ratio: Discounted ValuationCompressed
Percentile Rank33
3Y CAGR-51.1%
Studio
Year-over-Year Change

Price-to-book ratio

3Y CAGR
-51.1%/yr
Annual compound
Percentile
P33
Within normal range
vs 3Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive growthCompressed
PeriodValueYoY Change
20253.32+53.8%
20242.16-94.6%
202340.05+41.0%
202228.41-